McqMate
Arun Patel
1 day ago
I've been using liposomes and polymeric nanoparticles separately, but when I try to load both a chemotherapeutic drug and a targeting agent, I face issues like premature drug release or aggregation. I'm aiming for a system that can be scaled up for preclinical studies, and I've read about some hybrid approaches but can't find practical implementation details. Any advice on recent methods or tools would be great!
No comments yet